Skip to content

Comparison of frontal electroencephalogram during tasks and resting-state in Alzheimer's disease and mild cognitive impairment with healthy controls: a pilot study

Comparison of frontal electroencephalogram during tasks and resting-state in Alzheimer's disease and mild cognitive impairment with healthy controls: a pilot study - Comparison of frontal electroencephalogram during tasks and resting-state in Alzheimer's disease and mild cognitive impairment with healthy controls: a pilot study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000042372
Enrollment
60
Registered
2020-12-01
Start date
2020-10-30
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer&#39

Interventions

None listed

Sponsors

Keio University School of Medicine, Department of Neuropsychiatry
Lead Sponsor
Keio University, Faculty of Science and Technology Asaka Hospital Shonan Keiiku Hospital Tsutsuji Mental Hospital
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: For Alzheimer's disease 1) Patients diagnosed with Alzheimer's disease according to the DSM-5 diagnostic criteria 2) Patients who have been judged by their doctors to have the capacity to make consent decisions and who have a full understanding of the study or who have received consent from a surrogate. For MCI 1) Patients diagnosed with MCI according to DSM-5 diagnostic criteria 2) Patients who have been judged by their doctors to have the capacity to make consent decisions and who have a full understanding of the study or who have received consent from a surrogate For healthy individuals 1) Healthy individuals with no history of mental illness who have volunteered to participate in the study through web advertisements, bulletin boards, email announcements, etc., or through their organizations

Exclusion criteria

Exclusion criteria: 1) Patients with some kind of physical disease that would make it difficult to measure EEG with a simple bipolar electroencephalography system (e.g., frontal skin disease or skull defect) 2) Patients with neurological or physical diseases that can affect EEG (e.g., brain tumor, stroke, epilepsy, disturbance of consciousness) 3) Patients receiving treatments that are likely to have a significant effect on EEG results (e.g., antiepileptic medication) 4) A person suffering from a mental illness other than dementia 5) When the principal investigator or sub-investigator decides that it is inappropriate to conduct

Design outcomes

Primary

MeasureTime frame
EEG In particular, each frequency after the Fourier or Hilbert transforms and the amplitude variation of each frequency in the EEG during the measurement times will be involved.

Secondary

MeasureTime frame
Mini-Mental State Examination (MMSE) Montreal Cognitive Assessment (MoCA-J) Logical memory Stroop test Digit span test Trail making test B Word Fluency Test Ray Auditory Verbal Learning Test Rey -Osterrieth Complex Figure Test

Countries

Japan

Contacts

Public ContactToshiro Horigome

Keio University School of Medicine Department of Neuropsychiatry

toshiro@keio.jp03-5363-3492

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026